Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies

Advances in therapy in recent years have led investigators to challenge the dogma that multiple myeloma (MM) is incurable. We assessed overall (OS) and progression-free survival (PFS) of young patients ( ≤ 50 years) with MM and compared outcomes with follicular lymphoma (FL), diffuse large B-cell ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravi, Praful, Kumar, Shaji K., Cerhan, James R., Maurer, Matthew J., Dingli, David, Ansell, Stephen M., Rajkumar, S. Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849889/
https://www.ncbi.nlm.nih.gov/pubmed/29531285
http://dx.doi.org/10.1038/s41408-018-0065-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849889/
https://www.ncbi.nlm.nih.gov/pubmed/29531285
http://dx.doi.org/10.1038/s41408-018-0065-8

Ejemplares similares